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Stress-induced changes in 
social dominance are scaled by 
AMPA-type glutamate receptor 
phosphorylation in the medial 
prefrontal cortex
Min-Jung Park, Bo Am Seo, Boyoung Lee  , Hee-Sup Shin & Myoung-Goo Kang  
The establishment and maintenance of social dominance are critical for social stability and the survival 
and health of individual animals. Stress lead to depression and a decrease in the social status of 
depressed persons is a risk factor for suicide. Therefore, we explored the mechanistic and behavioral 
links among stress, depression, and social dominance and found that mice subjected to chronic restraint 
stress (CRS), an animal model of stress-induced depression, showed decreased social dominance 
as measured by a dominance tube test. Importantly, this submissive behavior was occluded by the 
antidepressant, fluoxetine, a selective serotonin reuptake inhibitor. It is known that social dominance 
is controlled by synaptic efficacy in the medial prefrontal cortex (mPFC) and that AMPA-type glutamate 
receptor (AMPA-R) is a key molecule for synaptic efficacy. We found that the phosphorylation on 
AMPA-R was bidirectionally changed by CRS and fluoxetine in the mPFC of mice with CRS. Moreover, 
we found a strong correlation between social dominance and AMPA-R phosphorylation that regulates 
synaptic efficacy by modulating the synaptic targeting of AMPA-R. Our correlational analysis of the 
behavior and biochemistry of the CRS model suggests that AMPA-R phosphorylation in the mPFC may 
serve as a biomarker of social dominance related to stress.
Social dominance is a social structure of an animal group based on the relative social rank of its members1,2. 
Dominance status is critical for social stability and the survival and health of individual animals3–5. Stress and 
social behaviors are deeply intertwined6. In both humans and rodents, chronic stress induces numerous patho-
physiological effects on brain function and behaviors such as depressive-like symptoms7,8 and a decrease in the 
social status of depressed patients is a risk factor for suicide9. It has been suggested that chronic stress could alter 
social dominance behavior10. In addition, stress is highly associated with a low rank in a social hierarchy6,11,12. An 
analytical study of the social context–dependent relationships between mouse dominance and plasma corticos-
terone, a stress hormone, found that subordinate males living in social hierarchies had significantly higher levels 
of plasma corticosterone than alpha males and pair-housed subordinate males11. These results suggest possible 
mechanistic and behavioral links among stress, depressive-like behaviors and social dominance.
The serotonergic system is involved in the modulation of social dominance and depressive-like behaviors. 
Elevated cortisol levels lower serotonin function in the brain leading to the depressive state13. Selective serotonin 
reuptake inhibitors (SSRIs) are the most widely prescribed antidepressants14. Serotonin has been shown to be 
closely linked to social dominance3. Polymorphisms of the serotonin transporter gene variation are associated 
with variation in the perception of social status within social hierarchies in human and non-human primates15. 
Social dominance modulates internal serotonin levels, and serotonin levels can modulate the hierarchy of vervet 
monkeys3,16. A similar effect of serotonin on social dominance of humans has also been reported. A group of 
people who ate meals including tryptophan (3 g/day), a precursor of serotonin, for 12 days showed a significant 
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Figure 1. Chronic stress induced depressive-like behaviors, which were occluded by fluoxetine. (a) 
Experimental timeline of chronic restraint stress (CRS), open-field test (OFT), tail suspension test (TST), 
social interaction (SI), forced swimming test (FST), sucrose preference test (SPT), dominance tube test, and 
dissection. CRS was applied to mice for 21 days with or without fluoxetine (FLU, 10 mg/kg). Control (CON) 
and CRS mice were injected with saline solution. (b) In the TST, immobility was higher in the CRS group 
compared with the CON group. One-way ANOVA: F(2, 27) = 27.32, ****p < 0.0001. CON (71.80 ± 10.06, 
n = 10) vs CRS (159.3 ± 13.72, n = 10), ****p < 0.0001; CRS vs CRS + FLU (45.50 ± 10.02, n = 10), 
****p < 0.0001. (c) In the FST, immobility was higher in the CRS group compared with the CON group. One-
way ANOVA: F(2, 27) = 46.59, ****p < 0.0001. CON (45.00 ± 6.393, n = 10) vs CRS (127.4 ± 5.747, n = 10), 
****p < 0.0001; CRS vs CRS + FLU (40.60 ± 8.947, n = 10), ****p < 0.0001. (d) In the SPT, sucrose preference 
was significantly reduced in the CRS group compared with the CON group. One-way ANOVA: F(2, 9) = 9.433, 
*p = 0.0062. CON (81.31 ± 2.841, n = 10) vs CRS (56.56 ± 4.068, n = 10), **p = 0.0059; CRS vs CRS + FLU 
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increase in dominant behavior compared to the control group17. Other neurotransmitters such as dopamine18, 
oxytocin19, and novel neuropeptides B and W20 are also known to be associated with social dominance.
Several brain regions are known to be involved in the perception and learning of social dominance, such as 
the amygdala, hippocampus, striatum, intraparietal sulcus, ventromedial prefrontal cortex, and lateral prefron-
tal cortex21. Specifically, the medial prefrontal cortex (mPFC) has been implicated in social cognition which is 
important for social hierarchy behavior22. Functional brain imaging in humans has shown that the dorsolateral 
prefrontal cortex (dlPFC) and mPFC are associated with dominance–related behaviors15,23. In the mouse brain, 
the functional homolog of the dlPFC and mPFC is the dorsomedial PFC, which includes the anterior cingulate 
cortex, prelimbic cortex, and infralimbic cortex24. Lesion of the mPFC lowers a rat’s social rank25. Furthermore, 
recent studies of dominance by Hu’s group with the dominance tube test have identified the mPFC as a control 
center for social dominance26,27. In the mPFC, excitatory synaptic efficacy is higher in dominant mice than in 
subordinates, and the bidirectional manipulation of synaptic efficacy in the mPFC alters social dominance26. 
The winning history alters thalamic input to the mPFC, leading to long-lasting changes in the social dominance 
status27. The functional synaptic activity in the mPFC has also been considered to be important for mediating key 
symptoms of depression induced by chronic social stress28. Therefore, the mPFC is likely a key brain region for 
stress, depression and social dominance.
Recent studies have implicated the AMPA-type glutamate receptor (AMPA-R) as a key molecule involved in 
the etiology of depression and in the action of antidepressants. In the brains of human patients with depressive 
symptoms (postmortem) and of rodent models of depression, the AMPA-R is significantly altered compared to 
control brains in terms of expression, subcellular localization, and post-translational modification. In addition to 
the mRNA/protein level of the AMPA-R itself, the expression of signaling molecules downstream of the AMPA-R 
are also affected by antidepressants29. The phosphorylation of the AMPA-R, which is known to be important for 
AMPA-R-mediated changes in the synaptic efficacy, is altered in the rodent model of depression. The phosphoryl-
ation of the AMPA-R is occluded by fluoxetine, an SSRI29. Conventionally, medicines that alter serotonergic and/
or noradrenergic neurotransmission have been widely used as antidepressants. The SSRI fluoxetine (Prozac) has 
traditionally been one of the most prescribed medicines for depression and is also used as a standard antidepres-
sant in many preclinical studies with animal models of depression. Because of the strong and reliable SSRI effects 
on depressive-like phenotypes such as immobility, which is simple and easy to evaluate, rodent models with stress 
have served in the screening of antidepressant candidates30. Recent, research has suggested a relationship between 
AMPA-R mediated neuronal activity changes in the mPFC and social dominance26,31.
To explore the mechanistic and behavioral links among stress, depression, and social dominance, we sub-
jected mice to chronic restraint stress (CRS) and analyzed depressive-like phenotypes such as social behav-
iors. The exposure to CRS significantly affected social behaviors such as social dominance in addition to other 
depressive-like behaviors. We found that the social behaviors were attenuated by stress, and the attenuation was 
occluded by fluoxetine co-treatment. Moreover, in the mPFC, one of the main brain regions controlling social 
dominance, the CRS and fluoxetine treatment bidirectionally changed the phosphorylation of the AMPA-R sub-
units (Ser818 and Ser831 of the GluA1 subunit and Ser880 of the GluA2 subunit). The phosphorylation is known 
to regulate synaptic efficacy. Furthermore, we found strong correlations between social dominance and the phos-
phorylation of the AMPA-R (Ser818 and Ser831). Our study evaluated social dominance in a mouse model of 
chronic stress through a correlational analysis of behavior and biochemistry, and suggests that AMPA-R phos-
phorylation in the mPFC may serve as a biomarker of social dominance related to stress.
Results
Chronic stress induced depressive-like behaviors, which were occluded by fluoxetine co-treat-
ment. To induce depressive-like behavior, we treated mice with CRS, followed by a series of behavioral anal-
yses of depressive-like phenotypes and dissection of mice for measurement of stress hormones in serum and 
harvesting of brain tissues (Fig. 1a). To induce chronic stress, two groups of mice were subjected to CRS (3 h 
per day for 21 days). In one group, fluoxetine was administered daily by intraperitoneal injection (10 mg/kg 
per day) 30 min before the restraint session for up to 3 weeks (CRS + FLU). As a negative control group, a 
group of mice was kept in cages with restriction of food and water for 3 h per day for 21 days after intraperito-
neal injection of saline solution (CON). The sham injection was also applied to the CRS group. One day after 
the final CRS, all groups of mice were given an open-field test (OFT), which showed no difference in locomo-
tion activity (Supplementary Fig. S1a,b ; one-way analysis of variance (ANOVA) with Bonferroni’s post hoc test, 
F (2, 27) = 0.1111, p = 0.8953) and anxiety (Supplementary Fig. S1c; F (2, 27) = 1.880, p = 0.1720) among the 
three groups. We examined the induction of depression by chronic stress by analyzing depressive-like behaviors 
with the tail suspension test (TST, Fig. 1b), the forced swimming test (FST, Fig. 1c), and the sucrose preference 
test (SPT, Fig. 1d). The results show that the CRS significantly increased immobility (Fig. 1b; F (2, 27) = 27.32, 
(77.46 ± 5.642, n = 10), *p = 0.0155. Consumption of water or 1% sucrose solution was measured for 2 days 
after 48 h of habituation of the two bottle conditions. (e) Total water consumption was not different between 
all groups during the SPT. One-way ANOVA: F(2, 9) = 0.9244, p = 0.4314. CON (35.25 ± 4.193, n = 10); CRS 
(39.25 ± 1.797, n = 10); CRS + FLU (29.75 ± 4.732, n = 10). (f) Corticosterone level in serum was analyzed after 
termination of the behavior tests by enzyme-linked immunosorbent assay. One-way ANOVA: F(2, 27) = 13.55, 
****p < 0.0001. CON (213.7 ± 36.14, n = 10) vs CRS (431.3 ± 46.10, n = 10), ***p = 0.0004; CRS vs CRS + FLU 
(193.4 ± 20.47, n = 10), ***p = 0.0001. (b–d,f) FLU treatment occluded the CRS effect on the TST, FST, and 
corticosterone level. Post hoc Bonferroni’s multiple comparisons revealed a significant difference between the 
three groups. Data are shown as mean ± SEM.
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Figure 2. Chronic stress impaired sociability and social novelty preference, which were occluded by fluoxetine. 
(a) Schema of the three-chamber test explaining procedure of three 10-min sessions. (b) Locomotion in three 
chambers was measured during habituation session (session 1), which showed no difference between groups. 
One-way ANOVA: F(2, 25) = 1.302, p = 0.2897. CON (2162 ± 91.46, n = 9); CRS (2526 ± 209.2, n = 10); CRS 
+ FLU (2298 ± 151.9, n = 9). (c) During sociability session (session 2), CON and CRS + FLU groups spent 
more time in social chamber than in empty chamber. However, the CRS group spent almost the same amount 
of time in the two chambers. One-way ANOVA: CON group; F(2, 24) = 21.97, ****p < 0.0001), social chamber 
(336.7 ± 36.94, n = 9) vs empty chamber (167.2 ± 26.03, n = 9), ***p = 0.0004. CRS group; F(2, 27) = 38.03, 
****p < 0.0001, social chamber (225.1 ± 14.85, n = 10) vs empty chamber (265.4 ± 13.76, n = 10), p = 0.0956. 
CRS + FLU group; F(2, 24) = 39.94, ****p < 0.0001, social chamber (307.0 ± 20.10, n = 9) vs empty chamber 
(196.7 ± 18.93, n = 9), ***p = 0.0003. (d) Social preference index was calculated by dividing the time spent in 
social chamber by total time spent, and expressing it as a percentage. CRS decreased this index significantly, 
and FLU occluded it. One-way ANOVA: F(2, 24) = 6.261, *p = 0.0065. CON (51.03 ± 3.930, n = 8) vs CRS 
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****p < 0.0001, Fig. 1c; F (2, 27) = 46.59, ****p < 0.0001) and anhedonia (Fig. 1d; F (2, 9) = 9.433, **p = 0.0062), 
which are two distinct depressive phenotypes in rodents. There was no difference in water consumption (Fig. 1e; 
F (2, 9) = 0.9244, p = 0.4314), indicating that the reduced sucrose preference associated with CRS was not due to 
a decrease in thirst or other physiological reasons. The higher level of corticosterone in the CRS group than in 
the control group (Fig. 1f; F (2, 27) = 13.55, ****p < 0.0001) confirmed the induction of stress by CRS and the 
prolonged effect of chronic stress during the period of behavioral analyses (days 22 to 33). It is known that the 
CRS effect was prolonged for a minimum of 4 weeks32. Moreover, the CRS effects were all occluded by fluoxetine 
co-treatment, suggesting that the CRS effect on these behaviors could be controlled by the serotonergic system 
in the brain.
Chronic stress decreased sociability and social novelty preference, which was occluded by 
fluoxetine co-treatment. A symptom of depression induced by stress is impairment in social function-
ing. It is also known that the negative symptoms of sociability, such as social anhedonia and avoidance of social 
interaction (SI), are observed in mouse models of depression induced by stress33. We tested whether CRS induced 
changes in social behavior, sociability, and social novelty (Fig. 2).
The sociability test was performed through three consecutive sessions for 10 min each using three-chambered 
boxes (Fig. 2a). Session 1 was the habituation period, during which the mice were allowed to freely move around 
chambers for 10 min. During habituation, there was no difference in the total distance of movement among the 
groups (Fig. 2b; F (2, 25) = 1.302, p = 0.2897). To measure the preference for sociability, mice were next placed 
in the middle chamber after an unfamiliar mouse in a cup had been placed in one of the two side chambers 
(social chamber; Fig. 2a). For 10 min of session 2, the control mice spent more time in the social chamber than 
in the empty chamber (Fig. 2c; CON, F (2, 24) = 21.97, ****p < 0.0001). However, the amounts of time the CRS 
mice spent in the two side chambers did not differ significantly (Fig. 2c; CRS, F (2, 27) = 38.03, ****p < 0.0001). 
Fluoxetine co-treatment occluded the impairments in sociability in the CRS group (Fig. 2c; CRS + FLU, F (2, 
24) = 39.94, ****p < 0.0001). The social preference index (the percentage of time spent in the social chamber 
during the 10 min) was significantly lower in the CRS group than in the control groups (Fig. 2d; F (2, 24) = 6.261, 
**p = 0.0065). In session 3, we tested social novelty. An unfamiliar mouse in a cup was placed in one of the two 
side chambers (novel chamber), and a familiar mouse from session 2 was placed in another side chamber (famil-
iar chamber; Fig. 2a). During the 10 min of session 3, the control group spent significantly more time in the novel 
chamber than in the familiar chamber (Fig. 2e; CON, F (2, 24) = 49.73, ****p < 0.0001). However, the amounts 
of time the CRS mice spent in the two side chambers did not differ significantly (Fig. 2e; CRS, F (2, 27) = 101.5, 
****p < 0.0001). Fluoxetine co-treatment again occluded the impairments in social novelty (Fig. 2e; CRS + FLU, 
F (2, 24) = 65.95, ****p < 0.0001). The social novelty index, the percentage of time spent in the novel chamber 
during the 10 min, was significantly lower in the CRS group than in the control groups (Fig. 2f; F (2, 25) = 7.154, 
**p = 0.0035). These results demonstrate that chronic stress impaired sociability and social novelty preference 
and suggest that the stress-induced changes in the social behavior is modulated by the serotonergic system.
Social dominance was bidirectionally altered by stress and fluoxetine, and was highly corre-
lated with depressive-like phenotypes. To determine whether chronic stress affected social dominance, 
we decided to use the dominance tube test. This test has become popular as a standard test to measure the dom-
inance that underlies the social hierarchy of mice and rats for several reasons. The dominance tube test is a 
simple and reliable behavioral test that does not include a violent conflict situation. Basically, the only essential 
equipment is a narrow cylindrical tube through which a rodent can pass. Consistent results can be expected from 
day-to-day, and the dominance derived from the tube test is reproducible in other hierarchy tests. Furthermore, 
the dominance tube test can be used not only for familiar cage-mates from the same strain but also for unfamiliar 
non-cage-mates26,34.
Before the test trials, all mice were trained to adapt to the testing tube by being guided to traverse a testing tube 
in alternating directions for three successive days. We confirmed that all mice were able to pass through the tube 
freely. After training and habituation, unfamiliar mice from different cages were placed at opposite ends of the 
test tube and released so that the mice were able to meet in the middle of the tube. During the match, if a mouse 
pushed another mouse through the test tube, it was scored as a win. Each mouse was subjected to a total of four 
matches, and a mouse’s dominance was calculated as the percentage of wins out of the four matches (Fig. 3a). 
The CRS group had a lower percentage of wins against the CON group and the CRS + FLU group. However, the 
(37.52 ± 2.475, n = 10), *p = 0.0137; CRS vs CRS + FLU (51.16 ± 3.350, n = 9), *p = 0.0102. (e) During 
social novelty session (session 3), CON and CRS + FLU groups spent more time in novel chamber than 
in familiar chamber. However, the CRS group spent almost the same amount of time in the two chambers. 
One-way ANOVA: CON group; F(2, 24) = 49.73, ****p < 0.0001, familiar chamber (196.4 ± 16.97, n = 9) vs 
novel chamber (305.1 ± 16.02, n = 9), ****p < 0.0001. CRS group; F(2, 27) = 101.5, ****p < 0.0001, familiar 
chamber (281.4 ± 15.19, n = 10) vs novel chamber (242.8 ± 12.44, n = 10), *p = 0.0480. CRS + FLU group; 
F(2, 24) = 65.95, ****p < 0.0001, familiar chamber (230.9 ± 18.15, n = 9) vs novel chamber (301.8 ± 11.16, 
n = 9). (f) Social novelty index was calculated by dividing the time spent in novel chamber by total time spent, 
and expressing it as a percentage. CRS decreased this index significantly, and the index change was occluded 
by FLU. One-way ANOVA: F(2, 25) = 7.154, **p = 0.0035. CON (50.85 ± 2.670, n = 9) vs CRS (40.47 ± 2.073, 
n = 10), **p = 0.0053; CRS vs CRS + FLU (50.30 ± 1.860, n = 9), **p = 0.0083. (c–f) Post hoc Bonferroni’s 
multiple comparisons revealed a significant difference between three groups (or chambers). Data are shown as 
mean ± SEM.
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Figure 3. Social dominance was bidirectionally altered by stress and fluoxetine, and highly correlated with 
depressive phenotypes. (a) Schema of dominance tube test showing competition of two mice in a 30-cm cylindrical 
tube. The horizontal bar graph shows percentages of wins in the tube test. CON group (75%) showed higher win 
scores against the CRS group (25%). The CRS group (32%) showed lower win scores against CRS + FLU group 
(68%). The CON group (45%) showed about half wins against the CRS + FLU group (55%). Winning points were 
calculated by counting win number for each mouse, averaged and presented histogram. The winning points of 
the CRS group were significantly lower compared with those of the CON and CRS + FLU. CON (1.400 ± 0.2211, 
n = 10) vs CRS (0.500 ± 0.1667, n = 10), **p = 0.0044, Student’s t-test. CRS (0.7273 ± 0.2371, n = 10) vs CRS 
+ FLU (1.400 ± 0.1633, n = 10), *p = 0.0336, Student’s t-test. CON (0.900 ± 0.2333, n = 10) vs CRS + FLU 
(1.000 ± 0.2582, n = 10), p = 0.7771, Student’s t-test. (b–e) High correlation of winning points with the FST (a 
negative linear regression, R2 = 0.99, n = 30, ***p = 0.0002. Winning points were calculated by counting win 
number in the total of four matches for each mouse and averaged. (b) TST (a negative linear regression, R2 = 0.78, 
n = 30, *p = 0.0455) (c), sociability (a positive linear regression, R2 = 0.90, n = 27, *p = 0.0146) (d) and social 
novelty (a positive linear regression, R2 = 0.94, n = 28, *p = 0.0066) (e) indicate strong correlation between social 
dominance and those depressive phenotypes. Data are shown as mean ± SEM.
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percentage of wins was almost the same between the CON group and the CRS + FLU group (Fig. 3a). For statis-
tical analysis, the winning points for each group were calculated by counting the number of wins in a match (e.g., 
0, 1, 2) to compare the group differences. The CRS group had significantly fewer winning points than the con-
trol group (Fig. 3a; Student’s t-test, **p = 0.0044), suggesting that stress decreased social dominance. Fluoxetine 
occluded the CRS effect on social dominance (Fig. 3a; Student’s t-test, *p = 0.0336). Because the three groups of 
mice differed in body weight (Supplementary Fig. S1d ; F (2, 27) = 5.081, *p = 0.0134), we tried to match two mice 
with a similar body weight for the dominance tube test to reduce the potential effects of body weight on winning. 
For the weight-matching condition, some mice could not be used for the tube test. The dominance and submissive 
behaviors of each group from the tube test were confirmed by another dominance test, the urine marking test 
(Supplementary Fig. S2)
We also analyzed the correlation of the winning points for total matches (e.g., 0, 1, 2, 3, 4) from all groups 
with the results of the FST (R2 = 0.99, ***p = 0.0002), TST (R2 = 0.78, *p = 0.0455), social preference (R2 = 0.90, 
*p = 0.0146), and social novelty (R2 = 0.94, *p = 0.0066; Fig. 3b–e). We found strong correlations among winning 
points and depressive-like behaviors induced by stress, supporting our hypothesis that the decrease in social 
dominance was induced by chronic stress as were the other depressive-like phenotypes.
Using a well-standardized mouse model of chronic stress, we demonstrated that chronic stress induced alter-
ations in social dominance and that the stress-induced changes of social dominance were occluded by fluoxetine, 
which regulates the serotonergic system in the brain.
Phosphorylation of AMPA-R was bidirectionally altered by stress and fluoxetine, and was 
highly correlated with social dominance. To identify the molecular alterations that underlie the bidi-
rectional changes in social dominance associated with chronic stress and fluoxetine, we decided to analyze 
the AMPA-R phosphorylation in the mPFC. The mPFC has been known as a region involved in social domi-
nance15,23,25. Hu’s group clearly demonstrated that the mPFC is one of the chief brain regions controlling social 
dominance by manipulating the synaptic strength of the mPFC through a bidirectional alteration of synaptic 
expression of the AMPA-R26,27. Synaptic targeting of the AMPA-R is regulated by phosphorylation on AMPA-R 
subunits, resulting in the regulation of synaptic efficacy35. We hypothesized that the submissive behavior of the 
CRS mice was related to AMPA-R phosphorylation in the mPFC, and we analyzed the major phosphorylation 
sites on AMPA-R subunits GluA1 and GluA2, which are known to be involved in changes of synaptic efficacy: 
Ser818, Ser831, and Ser845 on GluA1 and Ser 880 on GluA2.
After the behavioral analyses described above, the mPFC was dissected out from each mouse brain and used 
for biochemical analysis of AMPA-R phosphorylation. As shown in the representative western blots (Fig. 4a) and 
quantification (Fig. 4b–g), the CRS significantly decreased the phosphorylation on Ser818 (pS818) and Ser831 
(pS831) of GluA1 (Fig. 4b; F (2, 12) = 4.390, *p = 0.0371, Fig. 4c; F (2, 12) = 20.38, ***p = 0.0001). The effects 
of CRS on pS818 and pS831 were occluded by fluoxetine, although the reversal was statistically significant only 
for pS831 (Fig. 4b,c). The phosphorylation on S845 (pS845) and total GluA1 were not significantly changed by 
CRS or fluoxetine, but there were small changes similar to that of pS818 and pS831 (Fig. 4d; F (2, 12) = 0.09224, 
p = 0.9125). The phosphorylation on S880 (pS880) of GluA2 was significantly changed only by fluoxetine (Fig. 4f; 
F (2, 12) = 6.772, *p = 0.0107). In contrast, the total GluA2 was significantly decreased by the CRS and was not 
affected by fluoxetine (Fig. 4g; F (2, 12) = 7.165, **p = 0.0090). Because the increase of pS818 and pS831 is essen-
tial for the synaptic targeting of GluA136–38, the decrease of pS818, pS831, and GluA2 by CRS would decrease the 
number of synaptic AMPA-R, resulting in low synaptic efficacy in the mPFC. However, the increase of pS818 
and pS831 by fluoxetine would increase the number of synaptic AMPA-R, resulting in an occlusion of the CRS 
effect on the synaptic efficacy in the mPFC. Our correlation analysis showed that the two phosphorylation sites 
on S818 (R2 = 0.88, *p = 0.017) and S831 (R2 = 0.84, *p = 0.027) of the GluA1 subunit of AMPA-R were highly 
correlated with winning points from the social dominance test (Fig. 4h,i). However, the correlations of winning 
points with the GluA1, GluA2, pS845, and pS880 sites were not statistically significant (Supplementary Fig. S3). 
These biochemical analyses of the CRS mouse mPFC and correlational studies with social dominance suggest that 
the phosphorylation of AMPA-R (pS818 and pS831) may contribute as a biomarker for social dominance changes 
induced by chronic stress and fluoxetine.
Discussion
To understand the molecular and cellular mechanisms of stress-induced changes in social dominance, we sought 
stress-specific molecular alterations in brain regions that could be occluded with a drug. Based on results from 
previous studies, we hypothesized that the AMPA-R in the mPFC is a key molecule for controlling changes in 
social dominance induced by chronic stress and administration of an SSRI. We tested our hypothesis using a 
well-established mouse model of stress-induced depression, CRS. Indeed, our data demonstrate that social dom-
inance was bidirectionally changed by stress and the SSRI fluoxetine (Fig. 3a), which accompanied changes in 
three phosphorylation sites on AMPA-R subunits in the mPFC (Fig. 4a–c,f). The AMPA-R phosphorylation was 
highly correlated with social dominance (Fig. 4h,i) and social behaviors that were induced by chronic stress 
(Supplementary Fig. S4). Altogether, our results suggest that the AMPA-R phosphorylation in the mPFC may 
serve as a biomarker for the bidirectional changes of social dominance brought by stress and fluoxetine. Therefore, 
our study could contribute to the design of a simple and efficient platform that could be used for the development 
of new drugs for the management of social dominance in depressed patients. For example, libraries of chemicals 
or molecules could be screened by analyzing the changes of AMPA-R phosphorylation in mPFC neurons cul-
tured in 96 wells, followed by a second round of behavioral screening using dominance tube tests of stressed mice 
injected with the candidate drugs.
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Figure 4. Phosphorylation of AMPA-R was bidirectionally altered by stress and fluoxetine, and highly 
correlated with social dominance. (a) Representative data from western blot analyses of AMPA-R subunits 
and their phosphorylation in the mouse mPFC. (b–g) Quantification of the western blot analyses of AMPA-R 
subunits and their phosphorylation demonstrated: significant decrease of the serine phosphorylation (pS) on 
818 and 831 of GluA1, significant increase of the pS on 880 of GluA2 by fluoxetine, and significant decrease 
of the GluA2 by CRS. (b) Quantification of the western blot analyses of pS818. One-way ANOVA: F(2, 
12) = 4.390, *p = 0.0371. CON (1.106 ± 0.1125, n = 5) vs CRS (0.7343 ± 0.0367, n = 5), *p = 0.0271; CRS vs 
CRS + FLU (1.046 ± 0.0602, n = 5), p = 0.1470. (c) Quantification of the western blot analyses of pS831. One-
way ANOVA: F(2, 12) = 20.38, ***p = 0.0001. CON (1.078 ± 0.05397, n = 5) vs CRS (0.7341 ± 0.04652, n = 5), 
**p = 0.0015; CRS vs CRS + FLU (1.209 ± 0.06152, n = 5), ****p < 0.0001. (d) Quantification of the western 
blot analyses of pS845. One-way ANOVA: F(2, 12) = 0.09224, p = 0.9125. CON (1.096 ± 0.09151, n = 5) vs CRS 
(0.8616 ± 0.07809, n = 5), p = 0.9118; CRS vs CRS + FLU (1.029 ± 0.1740, n = 5), p = 0.5955. (e) Quantification 
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We found bidirectional changes of phosphorylation of the AMPA-R subunits GluA1 and GluA2 as molecular 
mechanisms underlying social dominance (Fig. 4). In our study, pS818 and pS831 of GluA1 were significantly 
decreased by CRS. The increases in pS818 and pS831 are necessary for the synaptic incorporation of AMPA-R 
during long-term potentiation (LTP)36–38. LTP is the main mechanism for the increase of synaptic efficacy in 
many regions of the brain such as the mPFC and hippocampus39. Thus, it is likely that the decrease of pS818 
and pS831 decreased the synaptic efficacy in the mPFC, resulting in a decrease of social dominance (Fig. 3a). In 
contrast, fluoxetine returned the pS818 and pS831 back to normal levels in the CON group (Fig. 4c), which is 
likely a mechanism for the recovery of social dominance in the CRS + FLU group (Fig. 3a). In agreement with 
our findings, the SSRI tianeptine significantly increased pS831 in the frontal cortex and in the CA3 region of the 
hippocampus40. Fluoxetine also significantly increased the pS880 of GluA2 (Fig. 4f), which could be a mechanism 
for the recovery of social dominance in the CRS + FLU group (Fig. 3a). Recent studies indicated that antide-
pressant drugs modulate synaptic plasticity that enables behavioral changes, in addition to well-known effects 
on depressive states or depressive-like behaviors41. The increase of pS880 is involved in the internalization of 
GluA2 from the cell surface42,43, and the internalization of GluA2 could increase the calcium-permeable AMPA-R 
(CP-AMPA-R) because GluA2 blocks calcium influx through the AMPA-R. The increase of calcium influx at the 
synapse by the CP-AMPA-R could positively influence the signaling pathway involved in the synaptic plasticity44. 
For example, an increase of synaptic calcium influx activates kinases such as the CaMKII, resulting in enhanced 
synaptic efficacy45. Indeed, the CP-AMPA-R is involved in the induction of LTP46. Therefore, it is possible that 
chronic administration of fluoxetine increased synaptic plasticity through the increase of pS880 in AMPAR, 
which allowed reversal of the CRS effect on social dominance. Interestingly, only pS831 was significantly changed 
by CRS and fluoxetine. The other phosphorylation sites (pS818 and pS880) were significantly changed in only one 
direction by either CRS or fluoxetine (Fig. 4b,c,f). This difference in direction means that the physiological status 
of the brain in dominant and submissive animals is determined by more than one factor or signaling pathway. 
This result could mean that a submissive status could be changed into a dominant status even though the cause of 
the submissive status (stress) remains. To explore this possibility further, we performed additional experiments 
that can test if fluoxetine has its own effect on animal behavior and AMPA-R phosphorylation (Supplementary 
Figs S5 and S6). Fluoxetine was able to alter dominance, as well as, depressive-like behaviors (TST and FST). 
It has been shown that depressive-behavior in rodents can be relieved by fluoxetine treatment30,47. The signifi-
cant increase of dominance induced by fluoxetine (Supplementary Fig. S5) demonstrated that fluoxetine has its 
own effect on dominance. Moreover, phosphorylation of AMPA-R was also altered by fluoxetine (Supplementary 
Fig. S6), which indicated that fluoxetine has its own effect on AMPA-R phosphorylation at mPFC. These results 
strongly suggest that the modulation of AMPA-R phosphorylation in mPFC is a critical factor to change social 
dominance either by stress or fluoxetine. Furthermore, we tested if intra-mPFC injection of an AMPA recep-
tor blocker (NBQX) could antagonize the effects of fluoxetine. Dominance was significantly reduced by NBQX 
injection regardless of fluoxetine treatment (Supplementary Fig. S7). Altogether, these additional experiments 
(Supplementary Figs S5–S7) strongly support our hypothesis that AMPA-R phosphorylation in the mPFC serve 
as a biomarker of social dominance related to stress.
Previous studies of AMPA-R phosphorylation related to stress-induced depression and SSRI administration 
have focused mostly on the hippocampus and found changes only on pS845. AMPA-R phosphorylation in the 
hippocampus has been analyzed previously with a combination of stress and fluoxetine and shows no significant 
changes except pS84548. With fluoxetine, the phosphorylation of S845 in the hippocampus decreased under the 
stress condition in one study48 but increased in another study49. Similarly, imipramine (the classic tricyclic anti-
depressant) and the SSRI tianeptine increased pS845 in the hippocampus40,50.
Recently, Yang et al. reported that chronic unpredictable mild stress (CUMS) increases aggression and 
enhances social dominance51. In their study, fluoxetine prevents aggression without reducing social dominance. 
Aggression and dominance are not identical concepts, as mentioned in their discussion section. In many cases, 
aggression and dominance are not well correlated. Moreover, there are cases in which aggression and dominance 
change in opposite directions34. Indeed, the correlation between aggressiveness and social rank in the dominance 
tube test has not always been apparent. For example, the highest scoring mice from the dominance tube test did 
not appear to be more aggressive52. The opposite effects of chronic stress on social dominance between our study 
and that of Yang’s group are not easy to explain. The differences could be due to the different methods used to 
induce chronic stress; we used CRS, and Yang and colleagues used CUMS. The different stress-induction methods 
could result in differences in social dominance. Specifically, the difference in the fluoxetine effect on social dom-
inance could be due to the timing of treatment; we pre-treated our mice, whereas Yang and colleagues adminis-
tered the drug as a post-treatment. Yang’s study concluded that social dominance is regulated by the dopaminergic 
of the western blot analyses of GluA1. One-way ANOVA: F(2, 12) = 2.226, p = 0.1506. CON (1.000 ± 0.06877, 
n = 5) vs CRS (0.7979 ± 0.0400, n = 5), p = 0.1688; CRS vs CRS + FLU (0.9941 ± 0.1074, n = 5), p = 0.1852. (f) 
Quantification of the western blot analyses of pS880. One-way ANOVA: F(2, 12) = 6.772, *p = 0.0107. CON 
(1.032 ± 0.1031, n = 5) vs CRS (0.9127 ± 0.06751, n = 5), p = 0.5320; CON vs CRS + FLU (1.344 ± 0.08238, 
n = 5), *p = 0.0435. (g) Quantification of the western blot analyses of GluA2. One-way ANOVA: F(2, 
12) = 7.165, **p = 0.0090. CON (1.056 ± 0.08569, n = 5) vs CRS (0.6314 ± 0.07982, n = 5), **p = 0.0052; CRS 
vs CRS + FLU (0.8552 ± 0.07211, n = 5), p = 0.1874; CON vs CRS + FLU, p = 0.2675. (h,i) The phosphorylation 
on S818 and S831 is highly correlated with winning points in the tube test. pS818 vs winning points (a positive 
linear regression, R2 = 0.88, n = 14, *p = 0.017) and pS831 vs winning points (a positive linear regression, 
R2 = 0.84, n = 14, *p = 0.027). (b,c,f,g) Post hoc Bonferroni’s multiple comparisons revealed a significant 
difference between three groups. Data are shown as mean ± SEM.
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system in the hippocampus based on the effect of clozapine on hippocampal microtubule-associated protein 2 
and on aggression and social dominance. Clozapine is a nonspecific tricyclic antipsychotic drug that is known 
to affect several neurotransmitter receptors such as the GABAB receptor, NMDA receptor, and serotonin and 
dopamine receptors53–55. Due to the non-specificity of clozapine, its mechanism of action is not clear. In contrast, 
our findings on the effects of fluoxetine on social dominance are consistent with a previous study. Fluoxetine 
has been found to increase the social dominance of submissive rats in the paradigm of dominant-submissive 
relationships56.
Stress is an important modulator of social behaviors. Stress generally helps organisms to deal with situa-
tions that challenge their survival, and overcome threats to homeostasis57. However, sustained stress can have 
numerous pathophysiological effects on brain function and behavior57. In this study, we found that chronic stress 
lowered social dominance as well as triggering depressive-like behaviors in rodents. We also observed impaired 
sociability (Fig. 2c,d) and social novelty (Fig. 2e,f) in SI tests. Social preference and social novelty are positively 
correlated with social dominance (Fig. 3d,e), suggesting that CRS in this study did induce adverse effects on 
social behaviors. Interestingly, a level of corticosterone in serum, which was elevated in the CRS group display-
ing submissiveness, was occluded by fluoxetine co-treatment (Fig. 1f). Consistent with our finding, it has been 
known that acute increases in glucocorticoids promote aggressiveness in socially challenged animals, but chronic 
surges in glucocorticoids produce the opposite effect58. Plasma glucocorticoids decrease in the winning animals, 
but increase in the losers59,60. In addition, administration of glucocorticoids to a variety of species demonstrated 
that elevated levels of glucocorticoids decrease social dominance and promote submissiveness58,61–63. It is unclear 
how chronic stress induced corticosterone-triggered changes in social dominance. Generally, stress activates the 
hypothalamo-pituitary-adrenal axis resulting in a release of corticosterone (in most rodents) or cortisol (humans) 
from the adrenal glands. The released hormones then enter the brain and bind to two subtypes of their receptors, 
the mineralocorticoid receptor and glucocorticoid receptor64. One recent study has shown that glucocorticoid 
signaling in the mPFC plays an important role in stress-mediated changes in social dominance by inhibiting the 
action of glucocorticoid receptors31. Whether glucocorticoid signaling is directly related to the changes in social 
dominance and impairment in SI induced by our chronic stress model and whether it is associated with the phos-
phorylation status of AMPA-R in mPFC remain to be examined.
Our study demonstrated stress-mediated changes in social dominance using a mouse model of depression. 
We identified bidirectional changes in specific phosphorylation sites on AMPA-R in the mPFC induced by stress 
and fluoxetine, an antidepressant, as specific molecular alterations that underlie the stress-mediated changes in 
social dominance. The AMPA-R phosphorylation in mPFC may serve as a biomarker of social dominance related 
to stress and depressive-like behaviors.
Methods
Animals. All animal experiments were approved by the Institutional Animal Care and Use Committee 
(IACUC) of the Korea Advanced Institute of Science and Technology (KAIST) and the Institute for Basic Science 
(IBS), and have been performed accordingly. All methods were performed in accordance with the relevant guide-
lines and regulations. Thirty mice were used in a set of experiments with three groups (CON, CRS, and CRS + 
FLU). Initially, mice were equally distributed (10 per group). However, one or two mice from each group could 
not be used because of the lower body weight or immobility. The final number of mice used in each test are given 
in the figure legends. Six-week-old male C57BL/6J mice were purchased from a local vendor (Orient Bio, Korea). 
Mice were housed in groups of five per cage for the behavioral experiments. Mice were stressed starting at 7 weeks 
of age. The mice were maintained at room temperature (22 °C ± 0.5 °C) with food and water available ad libitum 
under controlled conditions at a 12-h light/12-h dark cycle. For all animal behavior tests, the observers were 
blinded to the group assignments.
Chronic restraint stress and drug treatments. Animals were randomly separated into control group 
(CON) or CRS group. The CRS group was randomly divided and received either normal saline solution (CRS) or 
fluoxetine (10 mg/kg; Sigma-Aldrich, St. Louis, Missouri) co-treatment (CRS + FLU). Fluoxetine was dissolved 
and diluted in normal saline solution, and administered by intraperitoneal injection 30 min before the restraint 
stress. CON mice received normal saline solution. For restraint stress, the mice were individually placed into 
50-mL polypropylene conical tubes with a nose-hole for ventilation, and they were exposed to restraint stress (3 h/
day) for 21 consecutive days. After restraint stress, mice were returned to the home cage. One day after the last day 
of stress, the mice were weighed and used for a series of behavioral assays.
Animal behavioral tests. The mice were placed in the behavior room for 30 min for room habituation with 
white noise (65 dB). All behavioral tests were performed during the light cycle (09:00 to 17:00) in a dedicated 
sound-proof chamber with white noise (65 dB) and under a dim light (10 lux). The OFT, SI, and dominance tube 
test were performed with an EthoVision XT9 video tracking system (EthoVision Version 9, Noldus, Netherlands). 
TST and FST were conducted by two observers to minimize error.
Open field test. The OFT was conducted based on our previous study65. Briefly, a mouse was placed in a 
white acrylic chamber (40 × 40 × 40 cm3) for 10 min to measure locomotor activity. An arena was designated 
as center zone (10 × 10 cm2). The mice were placed in a corner of the test box at the beginning of the test trial. 
During the test, the movement of mice in the chamber was recorded and automatically analyzed with EthoVision 
XT9 software. After every test, the chamber was cleaned with 75% ethanol.
Tail suspension test. The TST was adapted from a method described by Steru et al.66. We used a customized 
tail suspension boxes (55 cm height × 30 cm width × 11.5 cm depth; material, Matte brown acryl). In order to 
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prevent mice from interfering each other, each mouse was separated by a compartment (55 cm height × 15 cm 
width × 11.5 cm depth). Mice that climbed their tail or fell off the hanger were excluded from analysis. The immo-
bility time was measured for 7 min.
Forced swimming test. To measure immobility through the FST, we used the details of the paradigm from 
a previous report67. In brief, each mouse was placed in a Pyrex beaker (30 cm height, 16 cm diameter) containing 
23 °C water with a depth of 17 cm. All mice were forced to swim for 6 min. The mice were habituated for the first 
1 min, and the time of immobility was measured during the final 5 min.
Sucrose preference test. To assess anhedonia, the SPT was adapted from a previous study67. The mouse 
cages were modified to fit two water bottles. One bottle was filled with water containing 1% sucrose, and the other 
was filled with pure water. For two consecutive days, the mice were acclimatized to the two-bottle conditions. 
After acclimation, the mice were tested for two additional days. On each test day, the fluid levels were noted. The 
position of the bottles was interchanged during testing days. The data are presented as the percentage of sucrose/
total liquid consumption.
Social interaction. For the SI test, the three-chamber test was performed as previously described65. The 
amount of time spent in each chamber was video recorded and automatically analyzed using the EthoVision XT 
system.
Dominance tube test. Social dominance was measured using the tube test, which was adapted from Wang 
et al.26 The tube test apparatus is a Plexiglass tube with a length of 30 cm and an inside diameter of 2.6 cm. Small 
acrylic boxes (10 cm × 10 cm × 10 cm) were added to each end of the tube to facilitate the entry into the tube. For 
adaptation to the tube, each mouse was trained to run through the tube for three successive days. During the 
training trial, any highly anxious mice that were hesitant to enter the tube were not used for test trials. During the 
test trial, two mice with similar body weights from different groups were placed into opposite ends of the tube and 
guided to meet in the middle of the tube. A mouse that pushed the other mouse out of the tube was designated as 
the “winner” of that trial. During test trials, each trial progressed for 2 min, and each test mouse was challenged 
three times with a novel strange mouse from different groups (a match). For example, if a certain mouse won 
twice in succession, the test was stopped and the winner mouse got a score of 2, while the loser got a score of 0. 
If a mouse won in a first match, lost in a second match, and won again in the last match, the winner mouse got a 
score of 2, while the loser mouse got score of 1. Therefore, for the comparison between two groups in Fig. 3a, their 
winning points varied between 0 and 2. Total matches for each mouse were limited to four because of the body 
weight difference among groups. Therefore, for the correlation studies between behaviors and winning point of all 
three groups, winning point of each mouse varied between 0 and 4, providing an indication of the number of wins 
from a total of four matches per animal. Before each trial, the tube was cleaned with 75% ethanol.
Determination of corticosterone level. After the last behavioral test, the mice were sacrificed to collect 
blood via cardiac puncture, and the serum was isolated and stored at −80 °C. The corticosterone level in serum 
was determined by a corticosterone enzyme-linked immunosorbent assay kit according to the manufacturer’s 
instructions (Cayman Chemical, Ann Arbor, MI).
NBQX injection. NBQX (0.03 nmol/side) was administered unilaterally into either left or right prelimbic 
region (PL) in mouse brain 35 min before the dominance test. A Cannula tip (guide + dummy) was implanted to 
inject NBQX into the PL of mPFC. Saline infusion into PL was applied to the control group.
Total protein extraction and western blot analysis. Based on the information from a mouse brain 
atlas (Paxinos and Franklin, 2007), the mPFC corresponding to ~1.9–2.7 mm anterior to the bregma, which con-
tains the prelimbic and infralimbic cortices was dissected out from the mice using a Rodent Brain Slice Matrix 
(1 mm coronal intervals, ZIVIC Instruments). The tissue was homogenized with phosphate-buffered saline 
solution (PBS, Welgene, Korea) containing 0.32-M sucrose, 0.5-mM ethylenediaminetetraacetic acid, 0.5-mM 
ethylene glycol tetraacetic acid, 1% Triton X-100, 0.2% sodium dodecyl sulfate, protease inhibitor cocktail 
(Complete-EDTA free; Roche), and phosphatase inhibitor cocktail (PhosStop, Roche). The lysates were incu-
bated in a refrigerator for 2 h and were centrifuged at 14,000 g for 15 min in 4 °C. The concentration of protein was 
determined using a bicinchoninic acid assay (Thermo Scientific, Waltham, MA). Thirty micrograms of protein 
were used for the western blot. The blots were then blocked in PBS including 1% bovine serum albumin and 0.1% 
Tween-20 for 1 h at room temperature and incubated with the antibodies at 4 °C overnight. All primary antibodies 
used in our study, except the GluA1-pS818 antibody, were purchased and used in the dilution of GluA1 (1:2000, 
NeuroMab, CA), GluA1-pS831 (1:2000, Millipore), GluA1-pS845 (1:2000, Cell Signaling, Danvers, MA), GluA2 
(1:3000, Millipore), GluA2-pS880 (1:2000, Novus Biologicals, Littleton, CO), and β-actin (1:2000, Cell Signaling). 
The GluA1-pS818 antibody (1:1000) was made in a similar way to previous work36. The following day, the blots 
were washed and incubated with specific secondary antibodies using a horseradish peroxidase–linked goat 
anti-mouse IgG (1:10000, GenDEPOT, Barker, TX) and goat anti-rabbit IgG (1:10000, GenDEPOT) at room tem-
perature for 1 h. The blots were developed with enhanced chemiluminescence (SuperSignal, Thermo Sciences) 
and imaged with an image capturing system (ChemiDoc XRS, Bio-Rad). For quantification of the western blots, 
the protein signals were measured and analyzed using ImageJ software (NIH, Washington, DC). To show the 
fidelity of our western blot analysis of AMPA-R phosphorylation, whole blots were presented as Supplementary 
Figures (Supplementary Figs S8 and S9).
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Statistical analysis. The statistical significance of differences among groups was assessed with Student’s 
t-test or one-way ANOVA. Linear regression was used to obtain a best-fit line for each plot. All data were pre-
sented as the mean ± standard error of the mean (SEM). A Bonferroni’s post hoc analysis was performed when 
p values were less than 0.05. All statistical analyses were performed using GraphPad Prism version 6.0 (La Jolla, 
CA).
Data Availability
All data generated or analyzed during this study are included in this published article (and its Supplementary 
Information files).
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